Answers are grounded in this paper and cite their sources.
With a broader objective to replace visible light driven Pt-based photoelectrochemical/catalytic hydrogen evolution, a series of cost-effective bimetallic nanoalloys of Cu–Ag have been deposited on core–shell nanostructured SiO 2 @TiO 2 through a facile reduction route. The physicochemical properties, i.e. crystal structure, morphology, chemical environment, and optical properties of Cu–Ag bimetal alloy decorated SiO 2 @TiO 2 hybrid photocatalyst, have been thoroughly investigated through X-ray diffraction, high resolution transmission electron microscopy, field emission scanning electron microscopy, X-ray photoelectron spectroscopy, UV–vis diffuse reflectance spectroscopy, and photoluminescence spectroscopy, respectively. TEM study confirms the coating of an ultrathin layer of TiO 2 shell on 100 nm sized SiO 2 core, and about 4.5 nm of Ag–Cu nanoalloys are uniformly distributed on the core–shell nanostructure. The higher light absorption throughout the visible range and better separation of charge carrier by Ag–Cu (1:3) deposited SiO 2 @TiO 2 hybrid compared to other counterparts is confirmed from UV–vis, diffuse reflectance spectroscopy, photoluminescence, and electrochemical impedance studies. Eightfold higher photocurrent enhancements, threefold enhanced photocatalytic hydrogen generation, and twofold higher phenol oxidation activities of Ag–Cu (1:3) deposited SiO 2 @TiO 2 hybrid compared to those of the monometallic plasmonic catalyst may be attributed to the synergetic effect of enriched light harvesting and surface plasmon induced hot electron transfer from the nanoalloy to the TiO 2 interface, resulting in efficient charge transfer.
No takes yet. Share an insight, caveat, or question.
Babu et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: